ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,628Medicare Part D Prescriptions Filled, Including Refills

Rank: 215 out of 2094

$902K Total Retail Price of All Prescriptions

Rank: 132 out of 2094

564 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 564 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 8,523 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$94 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 331 317 1 4
ZOLPIDEM TARTRATE 307 258 2 14
LEVOTHYROXINE SODIUM 276 224 3 3
AZITHROMYCIN 265 218 4 27
ATORVASTATIN CALCIUM 214 191 5 5
CRESTOR 189 172 6 15
METFORMIN HCL 186 182 7 8
PRAVASTATIN SODIUM 183 153 8 18
ALENDRONATE SODIUM 180 176 9 30
NEXIUM 164 124 10 16
PANTOPRAZOLE SODIUM 160 146 11 37
MELOXICAM 147 137 12 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 131 13 55
SIMVASTATIN 135 123 14 1
JANUMET 133 133 15 86
CARVEDILOL 132 117 16 19
LISINOPRIL 127 120 17 7
DIOVAN HCT 127 122 17 28
GLIMEPIRIDE 124 117 19 31
DIOVAN 122 95 20 13
LOSARTAN POTASSIUM 122 119 20 17
AMLODIPINE BESYLATE 121 114 22 2
GLYBURIDE-METFORMIN HCL 118 101 R 23 94
LEVOFLOXACIN 107 99 24 70
JANUVIA 101 96 25 35
LOVAZA 100 89 26 53
METHYLPREDNISOLONE 100 80 26 127
PLAVIX 98 91 28 38
TAMSULOSIN HCL 97 91 29 29
CLOPIDOGREL 95 93 30 22
LOSARTAN-HYDROCHLOROTHIAZIDE 88 66 31 52
CIPROFLOXACIN HCL 86 81 32 81
ENALAPRIL MALEATE 83 73 33 25
METOPROLOL TARTRATE 79 71 34 10
NAMENDA 78 78 35 32
LEXAPRO 76 61 36 180
NAPROXEN 76 69 36 84
ATENOLOL 73 72 38 21
LIDODERM 72 60 39 59
SINGULAIR 68 63 40 64
CLOTRIMAZOLE-BETAMETHASONE 65 60 41 91
DONEPEZIL HCL 64 64 42 20
METOPROLOL SUCCINATE 63 59 43 9
RAMIPRIL 62 62 44 48
HYDROCHLOROTHIAZIDE 61 60 45 12
WARFARIN SODIUM 60 59 46 11
ACTONEL 59 55 47 151
LIPITOR 58 48 48 39
PAROXETINE HCL 58 39 48 77
VESICARE 54 42 50 152
ESCITALOPRAM OXALATE 54 38 50 46
DEXILANT 54 33 50 124
VOLTAREN 53 46 53 109
FUROSEMIDE 52 41 54 6
IBANDRONATE SODIUM 52 45 54 140
MEGESTROL ACETATE 52 52 R 54 174
PREDNISONE 50 39 57 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.